Default company panoramic image

Next Healthcare Inc.

Next Healthcare Inc. enables individuals to obtain future regenerative medicine treatments by banking their own healthy cells today.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded November 2009
  • Employees 5
  • Website

Company Summary

Next Healthcare Inc. banks skin cells and stem cells for healthy individuals for future regenerative medicine applications. The services are offered though physicians around the country. Stem cell therapies using a patient's own cells are being administered and tested in the US and around the world. Our target customers are healthy, 35-55, forward thinking about health, and a family history of endocrine, cardiovascular, orthopedic ,and other.


  • Default avatar
    Vin Singh

    Founder, President, and CEO, is a seasoned executive from the biotechnology and life science industries. He has extensive start-up experience having helped build 4 companies in his career, one of which was a stem cell company that recently had a successful exit. Mr. Singh has eighteen years of industry experience primarily in cell therapy and stem cells both in senior level business development and technical roles with companies such as: GlobalSt

  • Default avatar
    Dennis O'Brien
    Chief Commercial Officer

    Chief Commercial Officer, Mr. O'Brien has over 18 years of leadership experience in medical products sales, marketing and operations. He has consulted with many US and European medical device companies in strategic marketing, business development and sales strategy. He has held positions as General Manager of US Surgical Operations, GM Canada and global leader of strategic marketing for the Lasik surgery business while with Bausch and Lomb. He s

  • Default avatar
    Wayne Hardy
    VP Technical Operations

    Vice President of Technical Operations, has over 20 years of progressive hands-on experience in biotechnology, molecular and cellular therapeutics industries with extensive experience in research & development, technology transfer, and manufacturing in regulated (cGMP, ISO13485) environments. He has held senior level manufacturing and quality roles with Osiris, ATCC and BioVeris. Mr. Hardy received a BS in Microbiology from University of Maryland


  • Default avatar
    Nixon Peabody